Global investment firm TPG has signed a legally binding agreement to purchase a 35% ownership in SCHOTT Poonawalla, the joint venture between Serum Institute of India (SII) and Germany-based SCHOTT ...

The transaction is subject to customary closing conditions and is expected to close within the first half of 2025.

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

SCHOTT Pharma, a provider of drug containment solutions and delivery systems for injectable drugs, announced that TPG — a ...

ReNew Energy has secured a ₹8,700 million ($100 million) investment from British International Investment (BII) to expand its ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

Global alternative asset management firm TPG has agreed to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII), according to an announcement on Tuesday. S ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

SCHOTT Pharma, a pioneer in drug containment and delivery solutions has announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35% ...

Global alternative asset management firm TPG has entered into a binding agreement to acquire a 35% stake in Schott Poonawalla ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...